Skip to content

USBC, INC.: 10-Q filed 2025-05-14

What USBC, INC. reported in its quarterly report filed 2025-05-14 (fiscal Q2 2025): 34 published measures, 95 facts as tagged in accession 0001654954-25-005607.

This filing

Form
10-Q (quarterly report)
Filed
2025-05-14
Fiscal period
fiscal Q2 2025
Accession
0001654954-25-005607 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All USBC, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-03-31924,185USD
At 2024-09-303,664,428USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-03-316,807,734USD
At 2024-09-305,820,629USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-03-31-5,883,549USD
At 2024-12-31-3,914,900USD
At 2024-09-30-2,156,201USD
At 2024-03-31-1,753,974USD
At 2023-12-311,225,889USD
At 2023-09-303,743,912USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-03-31443,913USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-01-01 to 2025-03-31-3,579,036USD90
2024-10-01 to 2025-03-31-8,244,544USD182
2024-10-01 to 2024-12-31-4,665,508USD92
2024-01-01 to 2024-03-31-5,397,664USD91
2023-10-01 to 2024-03-31-8,844,288USD183
2023-10-01 to 2023-12-31-3,446,624USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-10-01 to 2025-03-31-3,197,547USD182
2023-10-01 to 2024-03-31-7,047,684USD183

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2024-10-01 to 2025-03-310USD182
2023-10-01 to 2024-03-3112,696USD183

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-10-01 to 2025-03-31530,705USD182
2023-10-01 to 2024-03-313,746,354USD183

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2024-10-01 to 2025-03-310USD182
2023-10-01 to 2024-03-31-12,696USD183

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-03-31-147,036,640USD
At 2024-09-30-138,735,882USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-01-01 to 2025-03-312,909,985shares90
2024-10-01 to 2025-03-312,809,757shares182
2024-01-01 to 2024-03-312,044,153shares91
2023-10-01 to 2024-03-312,035,706shares183

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-01-01 to 2025-03-31-1.24USD/shares90
2024-10-01 to 2025-03-31-2.95USD/shares182
2024-01-01 to 2024-03-31-2.69USD/shares91
2023-10-01 to 2024-03-31-4.42USD/shares183

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2025-01-01 to 2025-03-310USD90
2024-10-01 to 2025-03-310USD182
2024-01-01 to 2024-03-310USD91
2023-10-01 to 2024-03-310USD183

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-03-3149,751USD
At 2024-09-3066,796USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2024-10-01 to 2025-03-311,144,384USD182
2023-10-01 to 2024-03-311,315,563USD183

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-03-31-2,207,522USD90
2024-10-01 to 2025-03-31-4,974,757USD182
2024-01-01 to 2024-03-31-4,726,093USD91
2023-10-01 to 2024-03-31-8,200,290USD183

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-03-31443,913USD
At 2024-09-303,110,755USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2024-10-01 to 2025-03-31124,600USD182

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-03-316,633,461USD
At 2024-09-305,163,379USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-01-01 to 2025-03-312,207,522USD90
2024-10-01 to 2025-03-314,974,757USD182
2024-01-01 to 2024-03-314,726,093USD91
2023-10-01 to 2024-03-318,200,290USD183

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2025-01-01 to 2025-03-311,789,315USD90
2024-10-01 to 2025-03-313,754,448USD182
2024-01-01 to 2024-03-312,550,848USD91
2023-10-01 to 2024-03-314,538,657USD183

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2025-01-01 to 2025-03-31418,207USD90
2024-10-01 to 2025-03-311,220,309USD182
2024-01-01 to 2024-03-312,175,245USD91
2023-10-01 to 2024-03-313,661,633USD183

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-03-313,541,707shares
At 2024-09-302,702,444shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-03-31443,913USD
At 2024-09-303,110,755USD
At 2024-03-314,709,690USD
At 2023-09-308,023,716USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-03-31141,037,185USD
At 2024-09-30136,468,855USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2025-03-31281,347USD
At 2024-09-30337,703USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2025-03-31287,214USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2025-03-31251,298USD
At 2024-09-30234,253USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2025-03-31380,217USD
At 2024-09-30101,582USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2025-01-01 to 2025-03-31-3,579,036USD90
2024-10-01 to 2025-03-31-8,244,544USD182
2024-01-01 to 2024-03-31-5,397,664USD91
2023-10-01 to 2024-03-31-8,844,288USD183

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2024-10-01 to 2025-03-31-8,244,544USD182
2023-10-01 to 2024-03-31-8,844,288USD183

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2025-01-01 to 2025-03-311,374,045USD90
2024-10-01 to 2025-03-312,557,844USD182
2024-01-01 to 2024-03-31716,814USD91
2023-10-01 to 2024-03-31740,251USD183

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-01-01 to 2025-03-31-1,371,514USD90
2024-10-01 to 2025-03-31-3,269,787USD182
2024-01-01 to 2024-03-31-671,571USD91
2023-10-01 to 2024-03-31-643,998USD183

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2024-10-01 to 2025-03-31200,000USD182
2023-10-01 to 2024-03-313,805,699USD183

Inspect the source

Entity
USBC, INC. / CIK 0001074828
Captured
SEC response SHA-256
26073072cc0b2e7e4070dcc10a3ed432c8710b50171436bfda5a00d8cb714978

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001074828.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))